EP3278792
Lyfjasamsetning með seinkaða losun
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
29.4.2013EP published:
20.2.2019EP application number:
17188821.7
EP translation filed:
26.4.2019Grant published:
15.5.2019EPO information:
European Patent Register
Max expiry date:
28.4.2033Expiry date:
28.4.2021
Title:
A DELAYED RELEASE DRUG FORMULATION
Timeline
Today
29.4.2013EP application
20.2.2019EP Publication
26.4.2019Translation submitted
15.5.2019Registration published
28.4.2021Expires
Owner
Name:
Tillotts Pharma AGAddress:
Baslerstrasse 15, 4310, Rheinfelden, CH
Inventor
Name:
BRAVO GONZÁLEZ, Roberto CarlosAddress:
Binningen, CH
Name:
BUSER, ThomasAddress:
Nuglar, CH
Name:
GOUTTE, Frédéric Jean-ClaudeAddress:
Schwoben, FR
Name:
BASIT, Abdul, WasehAddress:
Harrow, Middlesex HA3 8JB, GB
Name:
VARUM, Felipe, José, OliveriaAddress:
Basel, CH
Name:
FREIRE, Ana, CristinaAddress:
Riverside Wharf, Northampton NN4 8BY, GB
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
12166110Date:
30.4.2012Country:
EP
Number:
201261640217 PDate:
30.4.2012Country:
US
Classification
Categories:
A61K 9/00, A61K 9/28, A61K 31/606, A61K 47/32, A61K 47/36, A61K 9/20, A61K 31/196, A61K 31/616
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 5.4.2019
Expires: 28.4.2020
Payer: Árnason Faktor
Number: 8
Paid: 10.3.2020
Expires: 28.4.2021
Payer: Árnason Faktor ehf.